bio 316 presentation - acute myeloid leukemia (aml)
TRANSCRIPT
-
8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)
1/14
ACUTE MYELOID LEUKEMIAACUTE MYELOID LEUKEMIA
(AML)(AML)
Presented by Judi McCarter
-
8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)
2/14
Clinical Overview
Acute myeloid leukemia (AML) is one of four types ofleukemia.
AML is cancer of the blood-forming tissue (bone marrow).
Normal bone marrow produces red cells, white cells, and
platelets. AML causes bone marrow to produce too many immature
white blood cells (blast cells).
Suppresses normal blood cell production.
Anemia, leucopenia, thrombocytopenia
-
8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)
3/14
-
8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)
4/14
-
8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)
5/14
-
8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)
6/14
Signs and Symptoms
Fatigue
Shortness of breath on exertion
Easy bruising
Petechiae
Bleeding in the nose or from the gums
Prolonged bleeding from minor cuts
Recurrent minor infections or poor healing of minor cuts Loss of appetite or weight loss
Mild fever
-
8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)
7/14
11,920 new cases expected in U.S. in 2004
8,870 estimated deaths 2004 M:54%, F:46%
Statistics
5-year survival rate in adults under 65 is 33%
5-year survival rate in adults over 65 is 4%
Incidence:
Mortality:
Prognosis:
Prognosis:
Prognosis:
Incidence:
Mortality:
Prognosis:
Prognosis:
Prognosis: 20-30% experience remission or are cured
Sources: American Cancer Society, 2003; The Leukemia & Lymphoma Society, 2003
-
8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)
8/14
Risk Factors Age
Older adults are more likely to develop AML
Smoking 20% of AML cases are linked to smoking
Doubles the risk of disease in people older than 60 Genetic disorders
Down syndrome, Fanconis anemia
High doses of radiation Long-term survivors of atomic bombs
Previous chemotherapy treatment Breast cancer, ovarian cancer, lymphoma
Exposure to industrial chemicals Benzene
-
8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)
9/14
Treatments for AML
Chemotherapy
Phase One Remission induction therapy
Phase Two Remission continuation therapy Radiation therapy for certain cases
Bone marrow transplantation
-
8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)
10/14
-
8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)
11/14
The Future
Clinical trials
New drug treatments
Vaccines
Immunotherapy
Leukemia type-specific therapy
Gene therapy Block encoding instructions of an oncogene
Target the oncoprotein
Blood and marrow stem cell transplantation Bone marrow transplantation provides long-term, disease-freesurvival among patients in remission
-
8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)
12/14
Jillian had leukemia. She was only
one year old. She needed a
transplant, but no one in her family
was a match. Joe had joined the
Registry at the encouragement of a
friend. Brought together by the
National Marrow Donor Program,
this donor and recipient now have alife-long connection.
http://www.marrow.org
-
8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)
13/14
1-800-4MY-SDBB 1-800-469-7322
-
8/6/2019 BIO 316 Presentation - Acute Myeloid Leukemia (AML)
14/14
Questions??
Thank you.